NeuroPace, Inc. (Nasdaq: NPCE), a medical device company focused on transforming the lives of people living with epilepsy, today announced that it has filed a Premarket Approval Supplement (PMA-S) ...

A pilot deployment of a generative artificial intelligence (AI) registry identified patients with drug-resistant epilepsy ...

WEDNESDAY, Dec. 10, 2025 (HealthDay News) — Artificial intelligence (AI) can help improve treatment of epilepsy by connecting ...

Taylor Hyma's journey from enduring drug-resistant epilepsy to becoming seizure-free after brain surgery highlights hope and ...

How can cannabidiol (CBD) be used to treat epilepsy? This is what a recent study published in Neuropsychopharmacology hopes to address as a team of researchers investigated the potential for using CBD ...

AI-powered registries may improve epilepsy care by extracting data from incomplete medical records, easing the burden on clinicians when decisions are necessary regarding surgical evaluations, data ...

A new advance from Carnegie Mellon University researchers could reshape how clinicians identify the brain regions responsible ...

It is estimated that one-third of the 50 million people worldwide with epilepsy are resistant to anti-seizure medications. These patients, having drug-resistant epilepsy, have limited treatment ...

Mortality rates for Lennox Gastaut syndrome and Dravet syndrome, both developmental epileptic encephalopathies, were ...

She was a four-year college athlete, went on to be a Fitness Olympia competitor and participated in the International Federation of Bodybuilding & Fitness Professional League. Being a champion has ...

Emerging clinical and autopsy evidence points to late-onset epilepsy as a potentially distinct, neurodegeneration-related ...

LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, today announced it will present eight posters at the American Epilepsy Society (AES) Annual Meeting, taking place Dec. 5-9 in ...